Sandbox john: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) No edit summary |
Joao Silva (talk | contribs) |
||
Line 177: | Line 177: | ||
==Play Time== | ==Play Time== | ||
{| | |||
| valign=top | | |||
<div style="border-radius: 5px 5px 0 0; border: solid 1px #20538D; border-bottom: 0px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #A1BCDD; text-align: center;"> | |||
<font color="#FFF"> | |||
'''Pathogen-Based Therapy''' | |||
</font> | |||
</div> | |||
<div class="mw-customtoggle-table01" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #4479BA;"> | |||
<font color="#FFF"> | |||
▸ '''''Infants < 1 month''''' | |||
</font> | |||
</div> | |||
<div class="mw-customtoggle-table02" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #4479BA;"> | |||
<font color="#FFF"> | |||
▸ '''''Infants 1-3 months''''' | |||
</font> | |||
</div> | |||
<div class="mw-customtoggle-table03" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #4479BA;"> | |||
<font color="#FFF"> | |||
▸ '''''> 3 months Immunocompetent Children; Adults < 55 years''''' | |||
</font> | |||
</div> | |||
<div class="mw-customtoggle-table04" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #4479BA;"> | |||
<font color="#FFF"> | |||
▸ '''''Adults > 55 years; Alcoholics; Debilitating Illness''''' | |||
</font> | |||
</div> | |||
<div class="mw-customtoggle-table05" style="cursor: pointer; border-radius: 0 0 5px 5px; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 400px; background: #4479BA;"> | |||
<font color="#FFF"> | |||
▸ '''''Specific Situations''''' | |||
</font> | |||
</div> | |||
| valign=top | | |||
{| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table01" style="background: #FFFFFF;" | |||
| valign=top | | |||
{| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;" | |||
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Infants < 1 month}} | |||
|- | |||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Preferred Regimen''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Ampicillin]] 200 mg/kg/day IV, q4h''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | PLUS | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Cefotaxime]] 200 mg/kg/day IV, q6h''''' | |||
|- | |||
|} | |||
|} | |||
{| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table02" style="background: #FFFFFF;" | |||
| valign=top | | |||
{| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;" | |||
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Infants 1-3 months}} | |||
|- | |||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Preferred Regimen''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Ampicillin]] 200 mg/kg/day IV, q4h''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | PLUS | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Cefotaxime]] 200 mg/kg/day IV, q6h''''' <BR> OR <BR> ▸ '''''[[Ceftriaxone]] 100 mg/kg/day IV, q12h''''' | |||
|- | |||
|} | |||
|} | |||
{| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table03" style="background: #FFFFFF;" | |||
| valign=top | | |||
{| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;" | |||
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|> 3 months Immunocompetent Children; Adults < 55 years<sup>†</sup>}} | |||
|- | |||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Preferred Regimen''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Vancomycin]] Child: 60 mg/kg/day IV, q6h; Adult: 2 g/day IV, q12h''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | PLUS | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Cefotaxime]] Child: 200 mg/kg/day IV, q6h; Adult: 12 g/day IV, q4h''''' <BR> OR <BR> ▸ '''''[[Ceftriaxone]] Child: 100 mg/kg/day IV, q12h; Adult: 4 g/day IV, q12h''''' <BR> OR <BR> ▸ '''''[[Cefepime]] Child: 150 mg/kg/day IV, q8h; Adult: 6 g/day IV, q8h''''' | |||
|- | |||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=left | <SMALL><sup>†</sup> Might be added [[Metronidazole]] Child: 30 mg/kg/day, q6h; Adult: 1500-2000 mg/day, q6h</SMALL> | |||
|} | |||
|} | |||
{| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table04" style="background: #FFFFFF;" | |||
| valign=top | | |||
{| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;" | |||
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Adults > 55 years; Alcoholics; Debilitating Illness}} | |||
|- | |||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Preferred Regimen''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Ampicillin]] Child: 200 mg/kg/day IV, q4h; Adult: 12 g/day IV, q4h''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | PLUS | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Vancomycin]] Child: 60 mg/kg/day IV, q6h; Adult: 2 g/day IV, q12h''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | PLUS | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Cefotaxime]] Child: 200 mg/kg/day IV, q6h; Adult: 12 g/day IV, q4h''''' <BR> OR <BR> ▸ '''''[[Ceftriaxone]] Child: 100 mg/kg/day IV, q12h; Adult: 4 g/day IV, q12h''''' <BR> OR <BR> ▸ '''''[[Cefepime]] Child: 150 mg/kg/day IV, q8h; Adult: 6 g/day IV, q8h''''' | |||
|} | |||
|} | |||
{| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table05" style="background: #FFFFFF;" | |||
| valign=top | | |||
{| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;" | |||
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Specific Situations<sup>†</sup>}} | |||
|- | |||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Preferred Regimen''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Ampicillin]] Child: 200 mg/kg/day IV, q4h; Adult: 12 g/day IV, q4h''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | PLUS | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Vancomycin]] Child: 60 mg/kg/day IV, q6h; Adult: 2 g/day IV, q12h''''' | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | PLUS | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Ceftazidime]] Child: 150 mg/kg/day IV, q8h; Adult: 6 g/day IV, q8h''''' <BR> OR <BR> ▸ '''''[[Meropenem]] Child: 120 mg/kg/day IV, q8h; Adult: 3 g/day IV, q8h''''' | |||
|- | |||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=left | <SMALL><sup>†</sup> Hospital Acquired Meningitis; Posttraumatic Meningitis; Postneurosurgery Meningitis; Neutropenia; Impaired Cell-mediated Immunity</SMALL> | |||
|- | |||
|} | |||
|} | |||
|} |
Revision as of 16:26, 28 March 2014
Multiple Tables
- 1.
Unfavorable Prognostic Factors |
▸ Presenting with encephalopathy or coma |
▸ Younger than 10 years or elderly |
▸ Late start of antibiotics |
▸ Sterile cultures |
Favorable prognostic factors |
▸ Craniotomy instead of burr holes as surgical procedure |
▸ Early treatment |
▸ Young age (optimal between 10-20 years) |
▸ Patient presents awake, alert and oriented |
▸ Source of infection: paranasal sinuses |
▸ Aerobic streptococci isolated in culture |
▸ Aerobic streptococci as single pathogen |
- 2.
Unfavorable Prognostic Factors |
---|
▸ Presenting with encephalopathy or coma |
▸ Younger than 10 years or elderly |
▸ Late start of antibiotics |
▸ Sterile cultures |
Favorable Prognostic Factors |
▸ Craniotomy instead of burr holes as surgical procedure |
▸ Early treatment |
▸ Young age (optimal between 10-20 years) |
▸ Patient presents awake, alert and oriented |
▸ Source of infection: paranasal sinuses |
▸ Aerobic streptococci isolated in culture |
▸ Aerobic streptococci as single pathogen |
- 3.
Cardiovascular | No underlying causes |
Chemical/Poisoning | No underlying causes |
Dental | No underlying causes |
Dermatologic | No underlying causes |
Drug Side Effect | No underlying causes |
Ear Nose Throat | No underlying causes |
Endocrine | No underlying causes |
Environmental | No underlying causes |
Gastroenterologic | No underlying causes |
Genetic | No underlying causes |
Hematologic | No underlying causes |
Iatrogenic | No underlying causes |
Infectious Disease | No underlying causes |
Musculoskeletal/Orthopedic | No underlying causes |
Neurologic | No underlying causes |
Nutritional/Metabolic | No underlying causes |
Obstetric/Gynecologic | No underlying causes |
Oncologic | No underlying causes |
Ophthalmologic | No underlying causes |
Overdose/Toxicity | No underlying causes |
Psychiatric | No underlying causes |
Pulmonary | No underlying causes |
Renal/Electrolyte | No underlying causes |
Rheumatology/Immunology/Allergy | No underlying causes |
Sexual | No underlying causes |
Trauma | No underlying causes |
Urologic | No underlying causes |
Miscellaneous | No underlying causes |
Play Time
Pathogen-Based Therapy ▸ Infants < 1 month ▸ Infants 1-3 months ▸ > 3 months Immunocompetent Children; Adults < 55 years ▸ Adults > 55 years; Alcoholics; Debilitating Illness ▸ Specific Situations |
|